GUNA-VIRUS

Manufacturer: Guna spa
Effective date: 2022-11-14
Label type: HUMAN OTC DRUG LABEL
Version: 5
Source: full-release
Hydrated at: 2026-06-01 02:18:31

Label at a glance#

ProductGUNA-VIRUS

Active ingredientALDESLEUKIN, EVERLASTING EXTRACT, FOMITOPSIS PINICOLA FRUITING BODY, INTERFERON GAMMA-1B, METENKEFALIN, REISHI, BROWN RICE, SEROTONIN, SOYBEAN, SUS SCROFA BLOOD, SUS SCROFA SPLEEN, MELATONIN, SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE

Label structure10 sections

Indications and uses

Temporary relief of symptoms due to viral infection such as: Upper respiratory congestion Sore throat Cold sores

Dosage and administration

Turn tube upside down and rotate cap to release pellets into cap. Unscrew cap and without touching pellets tip them into the mouth under the tongue. Allow to dissolve Take 15 minutes before meals.

Contacts and useful links#

PhoneLabel contact(484) 223-3500

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS/PURPOSE

OTC - ACTIVE INGREDIENT SECTION

BETA ENDORPHIN        4C    PAIN RELIEVER
BLOOD            4C    IMMUNE SUPPORT
INTERFERON GAMMA    3C    IMMUNE SUPPORT
INTERLEUKIN 2        5C    IMMUNE SUPPORT
LIFE EVERLASTING    3X    COLD SORES
LING CHIN MUSHROOM    8X    IMMUNE SUPPORT
LYMPHATIC GLAND    4C 7C    IMMUNE SUPPORT
MELATONIN        4C 15C    ANTIOXIDANT
RICE            3X    IMMUNE SUPPORT
SEROTONIN        6X    NEUROTRANSMITTER
SOYBEAN            3X    ANTIOXIDANT
SPLEEN            4C    IMMUNE SUPPORT
TURKEY TAIL        8X    ANTIOXIDANT

USES

OTC - PURPOSE SECTION

Temporary relief of symptoms due to viral infection such as:

Upper respiratory congestion
Sore throat
Cold sores

WARNINGS

WARNINGS SECTION

Stop use and ask doctor if symptoms persist more than 5 days or worsen.
If pregnant or breast-feeding ask a health professional before use.
Keep out of reach of children.

PREGNANCY

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding ask a health professional before use.

WARNINGS

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

DIRECTIONS

INDICATIONS & USAGE SECTION

Turn tube upside down and rotate cap to release pellets into cap.
Unscrew cap and without touching pellets tip them into the mouth under the tongue.
Allow to dissolve
Take 15 minutes before meals.

QUESTIONS

OTC - QUESTIONS SECTION

Questions?: info@gunainc.com
tel. (484) 223-3500

DOSAGE & ADMINISTRATION SECTION

Adults and children twelve years and older: 5 pellets 3 times per day

Children between 12 years and 6 years of age: 3 pellets 3 times per day

Children under 6 years: 1 pellet 3 times per day to be dissolved into a little water

INACTIVE INGREDIENT SECTION

Inactive ingredient: Sucrose.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

USVIR-Guna-Virus-rev03-110718

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d45267e3-883a-4760-85b5-ebc565c21683	Product name	1	20150910

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
17089-251-20	2020-03-13	C162847	48780-1	9d75b9d0-74b9-f424-e053-dadaa90a57ce	GUNA-VIRUS
17089-251-20	2020-01-31	C162847	48780-1	9d75b9d0-74b9-f424-e053-dadaa90a57ce	GUNA-VIRUS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
17089-251-20	GUNA-VIRUS	4 g in 1 TUBE	PELLET	4		5
17089-251-20	GUNA-VIRUS	2 in 1 BOX	PELLET	2		5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17089-251	GUNA-VIRUS (ALDESLEUKIN - EVERLASTING EXTRACT - FOMITOPSIS PINICOLA FRUITING BODY - INTERFERON GAMMA-1B - MELATONIN - METENKEFALIN - REISHI - RICE - SEROTONIN - SOYBEAN - SUS SCROFA BLOOD - SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE - SUS SCROFA SPLEEN -) PELLET [GUNA SPA]	5	Current NDC, Legacy NDC, 2 package rows	20221115_4a5714f9-e0ab-41b2-b214-fed33c807358.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ALDESLEUKIN	ACTIVE INGREDIENT	M89N0Q7EQR	1
EVERLASTING EXTRACT	ACTIVE INGREDIENT	KQV867ADR4	1
FOMITOPSIS PINICOLA FRUITING BODY	ACTIVE INGREDIENT	30D02U2IRN	1
INTERFERON GAMMA-1B	ACTIVE INGREDIENT	21K6M2I7AG	1
MELATONIN	ACTIVE INGREDIENT	JL5DK93RCL	1
METENKEFALIN	ACTIVE INGREDIENT	9JEZ9OD3AS	1
REISHI	ACTIVE INGREDIENT	TKD8LH0X2Z	1
RICE	ACTIVE INGREDIENT	659G217HPG	1
SEROTONIN	ACTIVE INGREDIENT	333DO1RDJY	1
SOYBEAN	ACTIVE INGREDIENT	L7HT8F1ZOD	1
SUS SCROFA BLOOD	ACTIVE INGREDIENT	994R458ECK	1
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE	ACTIVE INGREDIENT	308LM01C72	1
SUS SCROFA SPLEEN	ACTIVE INGREDIENT	92AMN5J79Y	1
ALDESLEUKIN	ACTIVE MOIETY	M89N0Q7EQR	1
EVERLASTING EXTRACT	ACTIVE MOIETY	KQV867ADR4	1
FOMITOPSIS PINICOLA FRUITING BODY	ACTIVE MOIETY	30D02U2IRN	1
INTERFERON GAMMA-1B	ACTIVE MOIETY	21K6M2I7AG	1
MELATONIN	ACTIVE MOIETY	JL5DK93RCL	1
METENKEFALIN	ACTIVE MOIETY	9JEZ9OD3AS	1
REISHI	ACTIVE MOIETY	TKD8LH0X2Z	1
RICE	ACTIVE MOIETY	659G217HPG	1
SEROTONIN	ACTIVE MOIETY	333DO1RDJY	1
SOYBEAN	ACTIVE MOIETY	L7HT8F1ZOD	1
SUS SCROFA BLOOD	ACTIVE MOIETY	994R458ECK	1
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE	ACTIVE MOIETY	308LM01C72	1
SUS SCROFA SPLEEN	ACTIVE MOIETY	92AMN5J79Y	1
SUCROSE	INACTIVE INGREDIENT	C151H8M554	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

GUNA-VIRUS
aldesleukin - everlasting extract - fomitopsis pinicola fruiting body - interferon gamma-1b - melatonin - metenkefalin - reishi - rice - serotonin - soybean - sus scrofa blood - sus scrofa small intestine mucosa lymph follicle - sus scrofa spleen -
SUCROSE
ALDESLEUKIN
EVERLASTING EXTRACT
FOMITOPSIS PINICOLA FRUITING BODY
INTERFERON GAMMA-1B
METENKEFALIN
REISHI
BROWN RICE
SEROTONIN
SOYBEAN
SUS SCROFA BLOOD
SUS SCROFA SPLEEN
MELATONIN
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
17089-251	17089-251-20

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 14 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SUCROSE	C151H8M554	IACT
ALDESLEUKIN	M89N0Q7EQR	ACTIB
EVERLASTING EXTRACT	KQV867ADR4	ACTIB
FOMITOPSIS PINICOLA FRUITING BODY	30D02U2IRN	ACTIB
INTERFERON GAMMA-1B	21K6M2I7AG	ACTIB
METENKEFALIN	9JEZ9OD3AS	ACTIB
REISHI	TKD8LH0X2Z	ACTIB
BROWN RICE	659G217HPG	ACTIB
SEROTONIN	333DO1RDJY	ACTIB
SOYBEAN	L7HT8F1ZOD	ACTIB
SUS SCROFA BLOOD	994R458ECK	ACTIB
SUS SCROFA SPLEEN	92AMN5J79Y	ACTIB
MELATONIN	JL5DK93RCL	ACTIB
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE	308LM01C72	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 62 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SOLUTION / ORAL		42596 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SOLUTION / ORAL		38666 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, COATED / ORAL	516.42 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER / ORAL		27768 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	LIQUID / ORAL		37500 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, DELAYED RELEASE / ORAL		955 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED, EXTENDED RELEASE / ORAL		86 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TROCHE / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SOLUTION / ORAL		70000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, EXTENDED RELEASE / ORAL	284.54 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	WAFER / ORAL	155.2 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	POWDER, FOR SUSPENSION / ORAL		40017 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CONCENTRATE / ORAL		4800 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION / ORAL		48209 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SYRUP / ORAL		46400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION / ORAL		31885 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED / ORAL		145 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	PASTILLE / ORAL	426 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, EXTENDED RELEASE / ORAL		619 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION/ DROPS / ORAL		3750 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		18790 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	DROPS / ORAL	NA		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE, COATED PELLETS / ORAL	59.8 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET / ORAL		4249 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, DELAYED RELEASE / ORAL	295.33 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	ELIXIR / ORAL		18000 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	SUSPENSION, EXTENDED RELEASE / ORAL		5400 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	119.12 mg		Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	TABLET, CHEWABLE / ORAL		7258 mg	Exact identifier — unii+route 62 equally ranked IID candidates
SUCROSE	SUCROSE	C151H8M554	CAPSULE / ORAL		3568 mg	Exact identifier — unii+route 62 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
GUNA-VIRUS	ALDESLEUKIN - EVERLASTING EXTRACT - FOMITOPSIS PINICOLA FRUITING BODY - INTERFERON GAMMA-1B - MELATONIN - METENKEFALIN - REISHI - RICE - SEROTONIN - SOYBEAN - SUS SCROFA BLOOD - SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE - SUS SCROFA SPLEEN -	Guna spa	4a5714f9-e0ab-41b2-b214-fed33c807358	2022-11-14	Warnings	Exact identifier ndc (package): 17089-251-20 ndc (product): 17089-251 ndc11 (package): 17089025120 spl id: ed6d5169-d7e2-c4d7-e053-2a95a90a9ba7 spl set id: 4a5714f9-e0ab-41b2-b214-fed33c807358

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.